Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Related Articles by Review for PubMed (Select 23376451)

2.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity.

O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G.

Health Technol Assess. 2001;5(18):1-81. Review.

3.

Long-term pharmacotherapy for obesity and overweight.

Padwal R, Li SK, Lau DC.

Cochrane Database Syst Rev. 2004;(3):CD004094. Review.

PMID:
15266516
4.

Long-term pharmacotherapy for obesity and overweight.

Padwal R, Li SK, Lau DC.

Cochrane Database Syst Rev. 2003;(4):CD004094. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD004094.

PMID:
14584004
7.

Current and emerging drug treatments for binge eating disorder.

Reas DL, Grilo CM.

Expert Opin Emerg Drugs. 2014 Mar;19(1):99-142. doi: 10.1517/14728214.2014.879291. Epub 2014 Jan 25. Review.

8.

A systematic review of the clinical effectiveness of orlistat used for the management of obesity.

O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G.

Obes Rev. 2004 Feb;5(1):51-68. Review.

PMID:
14969507
9.

Weight management and current options in pharmacotherapy: orlistat and sibutramine.

Leung WY, Thomas GN, Chan JC, Tomlinson B.

Clin Ther. 2003 Jan;25(1):58-80. Review.

PMID:
12637112
10.

Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.

García Díaz E, Martín Folgueras T.

Nutr Hosp. 2011 May-Jun;26(3):451-7. doi: 10.1590/S0212-16112011000300004. Review.

11.

Rimonabant for the treatment of overweight and obese people.

Burch J, McKenna C, Palmer S, Norman G, Glanville J, Sculpher M, Woolacott N.

Health Technol Assess. 2009 Oct;13 Suppl 3:13-22. doi: 10.3310/hta13suppl3/03. Review.

12.

Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.

Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Kim C, Lau J.

Arch Intern Med. 2004 Jul 12;164(13):1395-404. Review.

PMID:
15249348
13.

What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.

Ara R, Blake L, Gray L, Hernández M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M, Abrams K, Cooper N, Davies M, Khunti K, Sutton A.

Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050. Review.

14.

Analysis of the XENDOS study (Xenical in the Prevention of Diabetes in Obese Subjects).

Sjöström L.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:31-3. Review.

PMID:
16627377
15.

Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.

Johansson K, Sundström J, Neovius K, Rössner S, Neovius M.

Obes Rev. 2010 Nov;11(11):777-91. doi: 10.1111/j.1467-789X.2009.00693.x. Review.

PMID:
20025693
16.

Long-term drug treatment for obesity: a systematic and clinical review.

Yanovski SZ, Yanovski JA.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361. Review.

17.

The effect of antiobesity drugs on waist circumference: a mixed treatment comparison.

Chilton M, Dunkley A, Carter P, Davies MJ, Khunti K, Gray LJ.

Diabetes Obes Metab. 2014 Mar;16(3):237-47. doi: 10.1111/dom.12198. Epub 2013 Sep 15. Review.

PMID:
23964810
18.

Benefit-risk assessment of orlistat in the treatment of obesity.

Sumithran P, Proietto J.

Drug Saf. 2014 Aug;37(8):597-608. doi: 10.1007/s40264-014-0210-7. Review.

PMID:
25064699
19.

Recent advancements in drug treatment of obesity.

Carter R, Mouralidarane A, Ray S, Soeda J, Oben J.

Clin Med. 2012 Oct;12(5):456-60. Review.

PMID:
23101148
20.

Therapeutic options for binge eating disorder.

Ramacciotti CE, Coli E, Marazziti D, Segura-García C, Brambilla F, Piccinni A, Dell'osso L.

Eat Weight Disord. 2013 Mar;18(1):3-9. doi: 10.1007/s40519-013-0003-5. Epub 2013 Apr 9. Review.

PMID:
23757245
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk